title: Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative?
authors.affiliation: a Department of Endocrinology , Hospices Civils de Lyon, Groupement Hospitalier Est , Bron , France ;
authors.forename: Lucien
authors.initials: L
authors.lastname: Marchand
authors.affiliation: b Department of Endocrinology , Centre Hospitalier de Vienne , Vienne , France ;
authors.forename: Cécile
authors.initials: C
authors.lastname: Nozières
authors.affiliation: c Department of Oncology , Hospices Civils de Lyon, Hôpital Edouard Herriot , Lyon , France ;|i Lyon 1 University , CRCL INSERM U1052.
authors.forename: Thomas
authors.initials: T
authors.lastname: Walter
authors.affiliation: d Department of Biochemistry , Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud , Pierre Bénite , France ;
authors.forename: Françoise
authors.initials: F
authors.lastname: Descotes
authors.affiliation: e Department of Pathology , Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud , Pierre Bénite , France ;
authors.forename: Myriam
authors.initials: M
authors.lastname: Decaussin-Petrucci
authors.affiliation: f Department of Central Anatomy and Pathological Cytology , Hospices Civils de Lyon, Hôpital Edouard Herriot , Lyon , France ;|i Lyon 1 University , CRCL INSERM U1052.
authors.forename: Marie-Odile
authors.initials: MO
authors.lastname: Joly
authors.affiliation: g Department of Radiology , Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud , Pierre Bénite , France ;
authors.forename: Véronique
authors.initials: V
authors.lastname: Lapras
authors.affiliation: h Department of Nuclear Medicine , Hospices Civils de Lyon, Groupement Hospitalier Est , Bron , France ;
authors.forename: Claire
authors.initials: C
authors.lastname: Bournaud
authors.affiliation: a Department of Endocrinology , Hospices Civils de Lyon, Groupement Hospitalier Est , Bron , France ;|i Lyon 1 University , CRCL INSERM U1052.
authors.forename: Françoise
authors.initials: F
authors.lastname: Borson-Chazot
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018278:Carcinoma, Neuroendocrine / Q000188:drug therapy* / Q000235:genetics* / Q000401:mortality; D019175:DNA Methylation; D015254:DNA Modification Methylases / Q000235:genetics; D045643:DNA Repair Enzymes / Q000235:genetics; D003606:Dacarbazine / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D009154:Mutation; D011401:Promoter Regions, Genetic; D051096:Proto-Oncogene Proteins c-ret / Q000235:genetics; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000401:mortality; D016896:Treatment Outcome; D025521:Tumor Suppressor Proteins / Q000235:genetics
chemical_list: D025521:Tumor Suppressor Proteins; D003606:Dacarbazine; D015254:DNA Modification Methylases; C515491:MGMT protein, human; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human; D045643:DNA Repair Enzymes; D005472:Fluorouracil